Clinical Trial Update: A Study of the Recombinant Human Interleukin-11 (I) (Baijieyi) for Prevention and Treatment of Chemotherapy-induced Thrombocytopenia in Patients With Malignant Tumor

View source ↗

Summary

Clinical trial update on recombinant human interleukin-11 (Baijieyi) for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with mali…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Malignant Neoplasm

Drugs mentioned

• Baijieyi (Interleukin-11)

Snippet

Sponsor: Angde Biotech Pharmaceutical Co., Ltd. | Conditions: Chemotherapy-induced Thrombocytopenia | Status: UNKNOWN